Literature DB >> 22484727

Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis.

Miguel Angel Arrabal-Polo1, Salvador Arias-Santiago, María Sierra Girón-Prieto, Felix Abad-Menor, Fernando López-Carmona Pintado, Armando Zuluaga-Gomez, Miguel Arrabal-Martin.   

Abstract

Calcium lithiasis is the most frequently diagnosed renal lithiasis and is associated with a high percentage of patients with metabolic disorders, such as hypercalciuria, hypocitraturia, and hyperoxaluria. The present study included 50 patients with recurrent calcium lithiasis. We conducted a random urine test during nocturnal fasting and a 24-h urine test, and examined calcium, oxalate, and citrate. A study of the linear correlation between the metabolites was performed, and the receiver operator characteristic (ROC) curves were analyzed in the random urine samples to determine the cutoff values for hypercalciuria (excretion greater than 200 mg), hyperoxaluria (excretion greater than 40 mg), and hypocitraturia (excretion less than 320 mg) in the 24-h urine. Linear relationships were observed between the calcium levels in the random and 24-h urine samples (R = 0.717, p = 0.0001), the oxalate levels in the random and 24-h urine samples (R = 0.838, p = 0.0001), and the citrate levels in the random and 24-h urine samples (R = 0.799, p = 0.0001). After obtaining the ROC curves, we observed that more than 10.15 mg/dl of random calcium and more than 16.45 mg/l of random oxalate were indicative of hypercalciuria and hyperoxaluria, respectively, in the 24-h urine. In addition, we found that the presence of less than 183 mg/l of random citrate was indicative of the presence of hypocitraturia in the 24-h urine. Using the proposed values, screening for hypercalciuria, hyperoxaluria, and hypocitraturia can be performed with a random urine sample during fasting with an overall sensitivity greater than 86%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484727     DOI: 10.1007/s00240-012-0474-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  26 in total

Review 1.  Metabolic evaluation and medical therapy for stone formation.

Authors:  A W Krautschick
Journal:  Curr Opin Urol       Date:  1999-07       Impact factor: 2.309

Review 2.  Evaluation of the recurrent stone former.

Authors:  Paramjit S Chandhoke
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

Review 3.  Pathophysiology and management of calcium stones.

Authors:  Sangtae Park; Margaret S Pearle
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

Review 4.  Epidemiology of stone disease.

Authors:  Gary C Curhan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

Review 5.  Economics of stone management.

Authors:  Yair Lotan; Margaret S Pearle
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

6.  Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements.

Authors:  Yet Hoi Hong; Norman Dublin; Azad Hassan Razack; Mustafa Ali Mohd; Ruby Husain
Journal:  Urology       Date:  2009-11-14       Impact factor: 2.649

Review 7.  Pathophysiology-based treatment of idiopathic calcium kidney stones.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  Clin J Am Soc Nephrol       Date:  2011-08       Impact factor: 8.237

8.  Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.

Authors:  Giovanna Capolongo; Khashayar Sakhaee; Charles Y C Pak; Naim M Maalouf
Journal:  Urol Res       Date:  2011-02-19

Review 9.  Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.

Authors:  Sonja Lewandowski; Allen L Rodgers
Journal:  Clin Chim Acta       Date:  2004-07       Impact factor: 3.786

Review 10.  Economics and cost of care of stone disease.

Authors:  Yair Lotan
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

View more
  3 in total

1.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

2.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

3.  Random urinary calcium/creatinine ratio for screening hypercalciuria in children with hematuria.

Authors:  In Su Choi; Eui Seok Jung; Young Earl Choi; Young Kuk Cho; Eun Mi Yang; Chan Jong Kim
Journal:  Ann Lab Med       Date:  2013-10-17       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.